Norway, May 21 -- Navamedic ASA announces the launch of Virono(R), the first over -the-counter single-dose treatment for recurrent cold sores (herpes labialis) in adults. The launch establishes a new OTC treatment category and represents an important step in Navamedic's Nordic Consumer Health growth strategy. Virono is available in Swedish pharmacies from May 2026. Roll-out activities have also been initiated in Finland, while launch in the Netherlands is planned later in 2026.Highlights * A new way to treat cold sores: one tablet per outbreak, applied once at the first sign of symptoms * Rx-to-OTC switch brings antiviral treatment into self-care for the first time in this format * Patented Lauriad(R) mucoadhesive buccal technology delivers...